1.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 52 to 75
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-R-01-PH-000018, NCT00134589
|
|
2.
|
Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: FHHS, NCT00750763
|
|
3.
|
Phase: Phase III, Phase II
Type: Educational/Counseling/Training, Screening
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-4547, PRC SIP 20-04, NCT00137592
|
|
4.
|
Phase: Phase III, Phase II
Type: Screening
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 190-CLD-AOS, NCT00867724
|
|
5.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 69 (40 to 69 at LSU site)
Sponsor: NCI
Protocol IDs: MSKCC-00046A, NCT00102011, UMN-2003NT062
|
|
6.
|
Phase: Phase III
Type: Screening
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-4527, U48/DP000057 (SIP 18-04), NCT00136227
|
|
7.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 25 to 65
Sponsor: Other
Protocol IDs: UHN04-0729-CE, NCT00188305
|
|
8.
|
Phase: Phase III
Type: Educational/Counseling/Training, Screening, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: IRB00000063, NCT00379743
|
|
9.
|
Phase: Phase III
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 to 74
Sponsor: NCI
Protocol IDs: TJUH-2006-44, 2006-44, NCT00617071
|
|
10.
|
Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CCFL-8964, NCT00687830
|
|
11.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 79
Sponsor: NCI
Protocol IDs: TJUH-RSGT-08-017-01-CPPB, RSGT-08-017-01-CPPB, 08G.89, NCT00893295
|
|
12.
|
Phase: Phase III
Type: Screening
Status: Approved-not yet active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792
|
|
13.
|
Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325
|
|
14.
|
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641
|
|
15.
|
Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163
|
|
16.
|
Phase: Phase I
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9461701245, NCT00302679
|
|
17.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Educational/Counseling/Training, Screening
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: FCCC-04827, NCT00450424
|
|
18.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: FDR, NCT00164944
|
|
19.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: COLOFOL, Danish Cancer Union 56 100 306, NCT00225641
|
|
20.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 9461700610, NCT00173277
|
|
21.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 HS013912-03, 5 R01 HS013912-03, NCT00251862
|
|
22.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Health services research, Screening
Status: Approved-not yet active
Age: 21 and over
Sponsor: Other
Protocol IDs: RA-2006-025, NCT00379782
|
|
23.
|
Phase: No phase specified
Type: Diagnostic, Educational/Counseling/Training, Screening
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 18388, 1A0CMS300067, NCT00380055
|
|
24.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: BRD 06/12-L, NCT00436514
|
|
25.
|
Phase: No phase specified
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: FCCC-05016, 05-016, FCCC-IRB-05-016, NCT00459030
|
